Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma
10.1016/j.bbcan.2010.05.002
Saved in:
Main Authors: | Lee, N.P., Poon, R.T.P., Shek, F.H., Ng, I.O.L., Luk, J.M. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Review |
Published: |
2016
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/125894 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma
by: Wang Y., et al.
Published: (2019) -
The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
by: Loh, C.-Y., et al.
Published: (2022) -
EVALUATING THE THERAPEUTIC POTENTIAL OF ORPHAN G-PROTEIN COUPLED RECEPTORS: GPR19 AND GPR17
by: ANGAD RAO
Published: (2017) -
HNF1α and CDX2 transcriptional factors bind to cadherin-17 (CDH17) gene promoter and modulate its expression in hepatocellular carcinoma
by: Zhu, R., et al.
Published: (2014) -
Proteomics of hepatocellular carcinoma: Serum vimentin as a surrogate marker for small tumors (≤2 cm)
by: Sun, S., et al.
Published: (2016)